131 related articles for article (PubMed ID: 10376972)
21. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
[TBL] [Abstract][Full Text] [Related]
22. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
23. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
[TBL] [Abstract][Full Text] [Related]
25. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
[TBL] [Abstract][Full Text] [Related]
27. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
Yang L; Wu D; Luo K; Wu S; Wu P
Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
Tejeda M; Gaál D; Hullán L; Schwab R; Szokoloczi O; Kéri G
Anticancer Res; 2007; 27(6B):4015-9. PubMed ID: 18225564
[TBL] [Abstract][Full Text] [Related]
29. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
[TBL] [Abstract][Full Text] [Related]
30. Role of constitutively activated and insulin-like growth factor-stimulated ERK1/2 signaling in human hepatoma cell proliferation and apoptosis: evidence for heterogeneity of tumor cell lines.
Alexia C; Lasfer M; Groyer A
Ann N Y Acad Sci; 2004 Dec; 1030():219-29. PubMed ID: 15659801
[TBL] [Abstract][Full Text] [Related]
31. Gypenoside induces apoptosis in human Hep3B and HA22T tumour cells.
Chen JC; Chung JG; Chen LD
Cytobios; 1999; 100(393):37-48. PubMed ID: 10643643
[TBL] [Abstract][Full Text] [Related]
32. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic mechanism of Octreotide action in human hepatoma.
Chen X; Liu Z; Ai Z
Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512
[TBL] [Abstract][Full Text] [Related]
34. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
Guo BC; Xu YH
Acta Pharmacol Sin; 2001 Sep; 22(9):831-6. PubMed ID: 11749866
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
36. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
[TBL] [Abstract][Full Text] [Related]
37. Anti-hepatoma activity of taxol in vitro.
Yuan JH; Wang XW; Luo D; Xie Y; Xie H
Acta Pharmacol Sin; 2000 May; 21(5):450-4. PubMed ID: 11324445
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines.
Yamanaka T; Shiraki K; Sugimoto K; Ito T; Fujikawa K; Ito M; Takase K; Moriyama M; Nakano T; Suzuki A
Hepatology; 2000 Sep; 32(3):482-90. PubMed ID: 10960439
[TBL] [Abstract][Full Text] [Related]
39. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
Kar S; Wang M; Carr BI
Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
[TBL] [Abstract][Full Text] [Related]
40. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.
Simbula G; Columbano A; Ledda-Columbano GM; Sanna L; Deidda M; Diana A; Pibiri M
Apoptosis; 2007 Jan; 12(1):113-23. PubMed ID: 17136495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]